相关临床试验
0
0 进行中
药物批准
0
批准总数
监管机构
0
监管机构数
成立时间
N/A
暂无试验阶段数据
暂无试验数据
暂无试验数据
暂无批准数据
- A Frankfurt Airport employee has died of malaria, with five additional employees infected and receiving medical treatment, according to airport operator Fraport. - The infections are attributed to a single mosquito believed to have traveled by plane from a malaria-endemic area to Germany, likely in July. - The Robert Koch Institute and Frankfurt Health Department describe "airport malaria" as a very rare transmission route, with human-to-human transmission playing no role. - A study of European airport and baggage-borne malaria from 1969 to 2024 identified 145 total cases, nine of which occurred in Germany.
- The 3rd Symposium on Artificial Intelligence in Public Health Research will take place September 9–10, 2026, at the Conference Centre of the German Federal Ministries in Berlin. - Hosted by the Centre for Artificial Intelligence in Public Health Research (ZKI-PH) at the Robert Koch Institute, the event expects approximately 200 participants from research, government, and international organizations. - Key topics include AI-supported decision-making for NCDs and infectious diseases, AI/ML for pandemic preparedness, regulatory frameworks and ethics, and climate change and public health. - The symposium is financially supported by the Federal Ministry of Health under the AI-DAVis project, with registration open until August 30, 2026.
- Researchers in Argentina reported that four of five hantavirus patients survived after receiving tocilizumab, a rheumatoid arthritis drug, compared to five deaths among patients who received only standard care. - The study represents the first use of tocilizumab in a compassionate use trial for hantavirus pulmonary syndrome, targeting the IL-6 inflammatory pathway that contributes to lung failure. - Multiple research teams are developing antibody treatments and vaccines for hantavirus, but limited funding and the virus's rarity have hindered progress despite mortality rates reaching 35-40%. - Recent cruise ship outbreak that killed three passengers has renewed attention to hantavirus research, with scientists hoping for increased investment in treatment development.
- The European Medicines Agency moved up its assessment meeting for the Pfizer-BioNTech COVID-19 vaccine from December 29 to December 21 following pressure from Germany and other EU nations. - Germany's Health Minister Jens Spahn expressed confidence in receiving approval before Christmas, stating the country has prepared 440 vaccination centers and activated 10,000 medical staff for immediate deployment. - The EMA subsequently approved the vaccine on December 21, enabling EU countries including Germany, France, Austria, and Italy to begin vaccination programs for vulnerable populations by the following Sunday. - Germany reported readiness to administer 3-4 million BioNTech doses in January and up to 11 million in the first quarter of 2021, targeting 60% population coverage by summer's end.
